These smaller losses may not seem as dramatic
This is a well-established physiological response
253,254 GLP-1 usually refers to GLP-1(7-36), a peptide chain consisting of 36 amino acids and the primary active molecule
This dual action provides: All the benefits of GLP-1 activation Additional metabolic benefits from GIP activation Enhanced insulin sensitivity Potentially greater appetite suppression Improved fat metabolism Clinical trials demonstrate that tirzepatide helps patients achieve an average weight loss of 20-22% of their body weightsignificantly more than semaglutide in head-to-head comparisons
Typically, individuals on Exenatide see a modest reduction in weight of about 3-5%, which is relatively minor when juxtaposed with alternative GLP-1 receptor agonists
Each patient begins with a comprehensive medical evaluation to determine clinically appropriate strategies based on metabolic, hormonal, and lifestyle factors